<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Knowledge Management and Communication in the Life Sciences</title>
	<atom:link href="http://brain.brainery.net/mcblog/?feed=rss2" rel="self" type="application/rss+xml" />
	<link>http://brain.brainery.net/mcblog</link>
	<description>The McCulley/Cuppan Blog on Tools and Strategies for Improving Quality of Knowledge Management and Communication in the Life Sciences</description>
	<lastBuildDate>Wed, 08 Sep 2010 20:12:46 +0000</lastBuildDate>
	<generator>http://wordpress.org/?v=2.9.2</generator>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
			<item>
		<title>More Regarding Merit of Peer Review</title>
		<link>http://brain.brainery.net/mcblog/?p=811</link>
		<comments>http://brain.brainery.net/mcblog/?p=811#comments</comments>
		<pubDate>Wed, 01 Sep 2010 19:19:52 +0000</pubDate>
		<dc:creator>gcuppan</dc:creator>
				<category><![CDATA[Communication of Science]]></category>
		<category><![CDATA[Improving Review Practices]]></category>
		<category><![CDATA[peer review]]></category>

		<guid isPermaLink="false">http://brain.brainery.net/mcblog/?p=811</guid>
		<description><![CDATA[Last week the New York Times had a major article devoted to web alternatives to peer review. Actually it does not describe an alternative to peer review but rather an alternative way of doing peer review via the web. The concept is not new, but by getting major coverage by the NYT, perhaps web-mediated review [...]]]></description>
		<wfw:commentRss>http://brain.brainery.net/mcblog/?feed=rss2&amp;p=811</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Regulatory Medical Writing Conference</title>
		<link>http://brain.brainery.net/mcblog/?p=805</link>
		<comments>http://brain.brainery.net/mcblog/?p=805#comments</comments>
		<pubDate>Thu, 12 Aug 2010 15:00:06 +0000</pubDate>
		<dc:creator>gcuppan</dc:creator>
				<category><![CDATA[Writing in the Life Sciences]]></category>
		<category><![CDATA[Document Review Practice]]></category>
		<category><![CDATA[improving writing practices]]></category>
		<category><![CDATA[medical writing]]></category>
		<category><![CDATA[report writing]]></category>
		<category><![CDATA[skills development]]></category>

		<guid isPermaLink="false">http://brain.brainery.net/mcblog/?p=805</guid>
		<description><![CDATA[I am a speaker at what I believe will be a very interesting regulatory medical writing conference on September 22-23. The conference is organized by ExL Pharma. Here&#8217;s a link to the conference program. Focus of the program is really spot on:

Uncover innovative strategies to streamline the document review process
Learn how the medical writing department is being consolidated and reorganized [...]]]></description>
		<wfw:commentRss>http://brain.brainery.net/mcblog/?feed=rss2&amp;p=805</wfw:commentRss>
		<slash:comments>2</slash:comments>
		</item>
		<item>
		<title>FDA and Lifestyle Drugs &#8212; The Next Chapter in the Story</title>
		<link>http://brain.brainery.net/mcblog/?p=799</link>
		<comments>http://brain.brainery.net/mcblog/?p=799#comments</comments>
		<pubDate>Wed, 21 Jul 2010 18:47:23 +0000</pubDate>
		<dc:creator>gcuppan</dc:creator>
				<category><![CDATA[Communication of Science]]></category>
		<category><![CDATA[drug development]]></category>
		<category><![CDATA[FDA]]></category>
		<category><![CDATA[Regulatory approval]]></category>

		<guid isPermaLink="false">http://brain.brainery.net/mcblog/?p=799</guid>
		<description><![CDATA[For those who may have missed the news from last week, Vivus Pharmaceuticals missed big time with Qnexa. Their FDA Endocrinologic and Metabolic Drugs advisory committee voted against recommending the anti-obesity drug for approval, basing their decision primarily on the absence of long-term safety data. The committee vote was 10 to 6 against approval.  A comment made [...]]]></description>
		<wfw:commentRss>http://brain.brainery.net/mcblog/?feed=rss2&amp;p=799</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>Technical Communication Myths</title>
		<link>http://brain.brainery.net/mcblog/?p=797</link>
		<comments>http://brain.brainery.net/mcblog/?p=797#comments</comments>
		<pubDate>Tue, 20 Jul 2010 11:17:31 +0000</pubDate>
		<dc:creator>gcuppan</dc:creator>
				<category><![CDATA[Writing in the Life Sciences]]></category>
		<category><![CDATA[technical writing]]></category>
		<category><![CDATA[writing in the life sciences]]></category>

		<guid isPermaLink="false">http://brain.brainery.net/mcblog/?p=797</guid>
		<description><![CDATA[My colleague Jessica Mahajan came across this post on the blog TechCommDood talking about common technical communication myths. Myths that apply to medical writing as well.
]]></description>
		<wfw:commentRss>http://brain.brainery.net/mcblog/?feed=rss2&amp;p=797</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
		<item>
		<title>FDA and Lifestyle Drugs&#8230;.Drawing a Line?</title>
		<link>http://brain.brainery.net/mcblog/?p=789</link>
		<comments>http://brain.brainery.net/mcblog/?p=789#comments</comments>
		<pubDate>Thu, 15 Jul 2010 03:30:04 +0000</pubDate>
		<dc:creator>gcuppan</dc:creator>
				<category><![CDATA[Communication of Science]]></category>

		<guid isPermaLink="false">http://brain.brainery.net/mcblog/?p=789</guid>
		<description><![CDATA[The winds at FDA appear to be shifting direction when it comes to &#8220;lifestyle&#8221; drugs.  The mood surrounding lifestyle drugs in FDA Advisory Committees suggests the approval bar may have been moved somewhere closer to the neighborhood of infinity.
Now I want to be clear that the precise definition of lifestyle drugs is a subject of [...]]]></description>
		<wfw:commentRss>http://brain.brainery.net/mcblog/?feed=rss2&amp;p=789</wfw:commentRss>
		<slash:comments>0</slash:comments>
		</item>
	</channel>
</rss>
